D
Mineralys Therapeutics, Inc. MLYS
$14.25 $0.755.56%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 66.63% 65.73% 82.12% 129.55% 173.40%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 127.27% 151.44% 179.63% 170.49% 168.93%
Operating Income -127.27% -151.44% -179.63% -170.49% -168.93%
Income Before Tax -147.31% -170.85% -195.48% -160.63% -141.28%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -147.31% -170.85% -195.48% -160.63% -141.28%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -147.31% -170.85% -195.48% -160.63% -141.28%
EBIT -127.27% -151.44% -179.63% -170.49% -168.93%
EBITDA -- -- -- -- --
EPS Basic -82.82% -4.68% 29.49% 54.44% 65.43%
Normalized Basic EPS -82.83% -4.68% 29.49% 54.44% 65.43%
EPS Diluted -82.82% -4.68% 29.49% 54.46% 65.45%
Normalized Diluted EPS -82.83% -4.68% 29.49% 54.44% 65.43%
Average Basic Shares Outstanding 34.24% 67.94% 132.65% 308.54% 599.36%
Average Diluted Shares Outstanding 34.24% 67.94% 132.65% 308.54% 599.36%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings